Browse
Submit Data
Databases
API
Help

Dataset Information

10 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

1,1-(Biphenyl-2,2'-diyldi-oxy)-3,3,5,5-tetra-kis-(4-bromo-methyl-phen-oxy)cyclo-triphosphazene.

ABSTRACT: In the title compound, C(40)H(32)Br(4)N(3)O(6)P(3), the cyclo-triphos-phazene ring adopts a planar conformation, with an r.m.s. deviation of 0.0247?Å. In the crystal, there is a weak inter-molecular C-H?O hydrogen bond as well as short inter-molecular Br?Br contacts [3.3352?(12)?Å].

SUBMITTER: Han R

PROVIDER: S-EPMC3120483 | biostudies-other | 2011 Jun

REPOSITORIES: biostudies-other

ACCESS DATA

Json Xml

Publications

1,1-(Biphenyl-2,2'-diyldi-oxy)-3,3,5,5-tetra-kis-(4-bromo-methyl-phen-oxy)cyclo-triphosphazene.

Han Rui R Chai Mei-Mei MM Yang Jun-Liang JL Ye Yong Y

Acta crystallographica. Section E, Structure reports online 20110507 Pt 6

In the title compound, C(40)H(32)Br(4)N(3)O(6)P(3), the cyclo-triphos-phazene ring adopts a planar conformation, with an r.m.s. deviation of 0.0247 Å. In the crystal, there is a weak inter-molecular C-H⋯O hydrogen bond as well as short inter-molecular Br⋯Br contacts [3.3352 (12) Å]. ...[more]

PMID: 21754703

Similar Datasets

Diethyl 2,2'-(biphenyl-2,2'-diyldi-oxy)diacetate.

Project description:In the title compound, C(20)H(22)O(6), the mean planes through the benzene rings make a dihedral angle of 59.82?(7)° with each other. Weak inter-molecular C-H?O inter-actions together with ?-? stacking inter-actions [centroid-centroid distance = 3.830?(1)?Å] between benzene rings are observed in the crystal packing.

| S-EPMC3007496 | biostudies-literature

Bis(?-4,4;6,6-bis-(biphenyl-2,2'-diyldi-oxy)-2,2-bis-{2-[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]phen-oxy}cyclo-triphosphazene)di-?-chlorido-bis-[chlorido-copper(II)].

Project description:In the crystal of the title compound, [Cu(2)Cl(4)(C(50)H(32)N(9)O(8)P(3))(2)], the binuclear mol-ecule is located across an inversion center. Each Cu(2+) cation is coordinated by two pyridine N atoms from symmetry-related 4,4;6,6-bis-(biphenyl-2,2'-diyldi-oxy)-2,2-bis-{2-[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]phen-oxy}cyclo-triphosphazene (L) ligands, a pair of bridging Cl(-) anions and a terminal Cl(-) anion, forming a distorted CuCl(3)N(2) square-pyramidal geometry. Weak intra-molecular C-H?O and inter-molecular C-H?N inter-actions occur in the crystal.

| S-EPMC3344371 | biostudies-literature

2,2'-(Biphenyl-2,2'-diyldi-oxy)diaceto-hydrazide.

Project description:In the mol-ecule of the title compound, C(16)H(18)N(4)O(4), the dihedral angle between the mean planes of the two benzene rings is 56.76?(5)°. The crystal structure reveals extensive inter-molecular hydrogen bonds between carbonyl O atoms and primary amines, as well as between primary and secondary amines of hydrazide, forming rings of R(2) (2)(10) and R(2) (2)(6) motifs, respectively. The structure is further stabilized by intra-molecular and non-classical hydrogen bonds of the types N-H?O and C-H?O, respectively. The structure does not show any ?-? inter-actions.

| S-EPMC2961455 | biostudies-other

cyclo-Tetra-kis{?-2,2'-dimethyl-1,1'-[2,2-bis-(bromo-meth-yl)propane-1,3-di-yl]di(1H-benzimidazole)-?N:N}tetra-kis-[bromidocopper(I)].

Project description:The title compound, [Cu(4)Br(4)(C(21)H(22)Br(2)N(4))(4)], features a macrocyclic Cu(4)L(4) ring system in which each Cu(I) atom is coordinated by one bromide ion and two N atoms from two 2,2'-dimethyl-1,1'-[2,2-bis-(bromo-meth-yl)propane-1,3-di-yl]di(1H-benzimidazole) (L) ligands in a distorted trigonal-planar geometry. The L ligands adopt either a cis or trans configuration. The asymmetric unit contains one half-mol-ecule with the center of the macrocycle located on a crystallographic center of inversion. Each bromide ion binds to a Cu(I) atom in a terminal mode and is oriented outside the ring. The macrocycles are inter-connected into a two-dimensional network by ?-? inter-actions between benzimid-azole groups from different rings [centroid-centroid distance = 3.803?(5)?Å.

| S-EPMC3274886 | biostudies-other

1-(4-Meth-oxy-phen-yl)ethane-1,2-diyl 1,1'-biphenyl-2,2'-dicarboxyl-ate.

Project description:In the title mol-ecule, C(23)H(18)O(5), the meth-oxy-substituted benzene ring makes dihedral angles of 65.12?(4) and 88.55?(4)° with the other two benzene rings. These two benzene rings form a dihedral angle of 45.70?(4)°. In the crystal, mol-ecules are linked into inversion dimers by pairs of weak C-H?O hydrogen bonds.

| S-EPMC3379233 | biostudies-literature

2,2,6,6-Tetra-kis(biphenyl-2-yl)-4,4,8,8-tetra-methyl-cyclo-tetra-siloxane.

Project description:The title compound, [-Si(C(12)H(9))(2)OSi(CH(3))(2)O-](2), was obtained unintentionally as the product of an attempted crystallization of caesium bis-(biphenyl-2,2'-di-yl)fluoro-silicate from dimethyl-formamide. In the crystal, the mol-ecule is located on an inversion center and the siloxane ring adopts a twist-chair conformation with the two dimethyl-substituted Si atoms lying 0.7081 (5) Å out of the plane defined by the two bis-(biphenyl-2-yl)-substituted Si atoms and the four O atoms. In each Si(C(12)H(9))(2) unit, the orientation of one terminal phenyl ring relative to the phenyl-ene ring of the other biphenyl moiety suggests a parallel displaced π-π stacking inter-action [centroid distance = 4.2377 (11) Å and dihedral angle = 15.40 (9)°].

| S-EPMC2969922 | biostudies-literature

2,2'-(Biphenyl-4,4'-diyldi-oxy)diacetic acid N,N-dimethyl-formamide solvate.

Project description:In the crystal struture of the title compound, C(16)H(14)O(6)·C(3)H(7)NO, the two crystallographically independent benzene rings are coplanar [dihedral angle = 1.00?(2)°]. The crystal structure is stabilized by O-H?O hydrogen bonds between the diacid and the solvate dimethylformamide mol-ecule, resulting in the formation of a zigzag chain structure extending parallel to [001].

| S-EPMC2977266 | biostudies-literature

2,2'-Dichloro-1,1'-[(propane-1,3-diyldi-oxy)bis-(nitrilo-methyl-idyne)]dibenzene.

Project description:The title compound, C(17)H(16)Cl(2)N(2)O(2), assumes a V-shape configuration with a dihedral angle between the two halves of the mol-ecule of 79.60?(4)°. The asymmetric unit comprises one half-mol-ecule with a crystallographic twofold rotation axis passing through the central C atom. There are weak inter-molecular ?-? stacking inter-actions between neighbouring benzene rings with inter-molecular plane-to-plane distances of 3.277?(6) and 3.465?(5)?Å along the a and c axes, respectively. In the crystal structure, weak inter-molecular C-H?O bonds link each mol-ecule to four others to form an infinite three-dimensional network.

| S-EPMC2962157 | biostudies-literature

2,2'-Dichloro-1,1'-[(pentane-1,5-diyldi-oxy)bis-(nitrilo-methyl-idyne)]dibenzene.

Project description:The mol-ecule of the title compound, C(19)H(20)Cl(2)N(2)O(2), which lies across a crystallographic inversion centre, adopts a linear configuration. The dihedral angle between the two halves of the mol-ecule is 5.14?(2)°. In the crystal structure, inter-molecular C-H?O hydrogen bonds link neighbouring mol-ecules into an infinite zigzag chain supra-molecular structure.

| S-EPMC2977418 | biostudies-literature

cyclo-Tetra-kis(?-naphthalene-1,8-dicarboxyl-ato)tetra-kis-[diaqua-(2,2'-bipyridine)-manganese(II)] tetra-hydrate.

Project description:In the title centrosymmetric tetra-nuclear complex, [Mn(4)(C(12)H(6)O(4))(4)(C(10)H(8)N(2))(4)(H(2)O)(8)]·4H(2)O, two independent Mn(II) ions are coordinated in a slightly disorted octa-hedral environment by two aqua ligands, two naphthalene-1,8-dicarboxyl-ate (1,8-nap) ligands and one bis-chelating 2,2'-bipyridine (2,2'-bipy) ligand. In the crystal, mol-ecules are linked by inter-molecular O-H?O hydrogen bonds into chains along [100]. These chains are further linked by weak ?-? inter-actions with centroid-centroid distances in the range of 3.609?(2)-3.758?(1)?Å, forming a three-dimensional supra-molecular network.

| S-EPMC3011697 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data